Joshua W. Purvis

Joshua W. Purvis

Auto-generated profile, based on publicly available information

Joshua W. Purvis

University of Alabama at Birmingham, Department of Anesthesia, Birmingham, AL, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
BOBabak J. Orandi
Babak J. Orandi
JPJoshua W. Purvis
Joshua W. Purvis
RCRobert M. Cannon
Robert M. Cannon
ASA. Blair Smith
A. Blair Smith
CLCora E. Lewis
Cora E. Lewis
JLJayme E. Locke
Jayme E. Locke

2 August 2021 in Obesity
Verified
Journal Article
Closed access
PDF file
BOBabak J. Orandi
Babak J. Orandi
CLCora E. Lewis
Cora E. Lewis
PMPaul A. MacLennan
Paul A. MacLennan
HQHaiyan Qu
Haiyan Qu
SMShikha Mehta
Shikha Mehta
JLJayme E. Locke
Jayme E. Locke

7 February 2021 in The American Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JPJoshua Purvis
Joshua Purvis
CMChandler McLeod
Chandler McLeod
BSBlair Smith
Blair Smith
BOBabak J. Orandi
Babak J. Orandi
CKCozette Kale
Cozette Kale
RCRobert M. Cannon
Robert M. Cannon

27 July 2023 in The American Journal of Surgery
Verified
Journal Article
Closed access
KFKayla L. Frey
Kayla L. Frey
MMM. Chandler McLeod
M. Chandler McLeod
RCRobert M. Cannon
Robert M. Cannon
SSSaulat S. Sheikh
Saulat S. Sheikh
JPJoshua W. Purvis
Joshua W. Purvis
BOBabak J. Orandi
Babak J. Orandi

30 September 2021 in Pediatric Transplantation
Verified
Journal Article
Open access
PDF file
JPJoshua W. Purvis
Joshua W. Purvis
BOBabak J. Orandi
Babak J. Orandi
DDDeepti Dhall
Deepti Dhall
CMChandler McLeod
Chandler McLeod
LSLuz Helena Gutierrez Sanchez
Luz Helena Gutierrez Sanchez
JLJayme E. Locke
Jayme E. Locke
Introduction: The pediatric obesity epidemic is associated with early development of hepatic macrosteatosis, a hallmark of non‐alcoholic fatty LI disease, which is thought to be more rapidly progressive in children than adults. Macrosteatosis in adult allografts is associated with allograft loss, but this has not been examined in pediatric donors.Methods: We studied all pediatric potential whole LI donors (2005–2018) who had a LI biopsy in the SRTR (n = 862) and whose LI was transplanted (n = 862). Macrosteatosis was abstracted from biopsy reports and compared to values in the SRTR standard analytic file. Recipients of macrosteatotic pediatric allografts were matched 1:1 to recipients of non‐macrosteatotic pediatric allografts by propensity score matching on donor/recipient variables. All‐cause allograft loss was estimated via Kaplan–Meier analysis and Cox proportional hazards model.Results: From 2005 to 2018, the proportion of pediatric donors (age ≥2 years) with obesity increased (14.8% to 21.7%; p < .001), as did the proportion of pediatric deceased whole LI‐only donor allografts with macrosteatosis (n = 10 648; 1.8% to 3.9%; p < .001). The median degree of macrosteatosis among macrosteatotic donors was 10% (IQR 5–30). There were no significant differences in all‐cause allograft loss between recipients of pediatric LI allografts with and without macrosteatosis at 90 days (p = .11) or 1 year (p = .14) post‐transplant in Kaplan–Meier analysis or a Cox proportional hazards model (p > .05).Conclusion: Obese pediatric LI donors have increased over time and were more likely to have hepatic macrosteatosis; however, pediatric macrosteatosis did not appear to adversely affect recipient outcomes.

15 December 2017 in Spinal Cord Series and Cases
Verified
Journal Article
Open access
PDF file
BWBrent Womble
Brent Womble
ETEdward Taub
Edward Taub
BHBrennan Hickson
Brennan Hickson
JPJoshua Purvis
Joshua Purvis
VMVictor W. Mark
Victor W. Mark
GUGitendra Anthony Uswatte
Gitendra Anthony Uswatte
Introduction The purpose of this case study was to determine if a subject with chronic high tetraplegia (C3 AIS A) could learn to use an initially paralyzed upper extremity on the basis of training procedures alone. Case presentation Initially, an AIS examination revealed no purposive movement below the neck other than minimal shoulder movement. Training was carried out weekly over 39 months. Training began based on electromyographic biofeedback; the electrical activity of a muscle (biceps or triceps) was displayed visually on a computer monitor and the subject was encouraged to progressively increase the magnitude of the response in small increments on a trial-by-trial basis (i.e., shaping). When small, overt movements began to appear; these were, in turn, shaped so that their excursion progressively increased. Training then progressed to enable lifting the arm with the aid of the counterweight of a Swedish Help Arm. Mean movement excursions in the best session were: internal rotation 52.5 cm; external rotation 26.9 cm; shoulder extension 22.1 cm; shoulder flexion 15.2 cm; pronation/supination 120°; extension of index finger (D2) 2.5 cm. Movements were initially saltatory, becoming smoother over time. With the Swedish Help Arm, the subject was able to lift her hand an average of 24.3 cm in the best session with 0.7 kg counterweight acting at the wrist (1.9 J of work). Discussion Results suggest in preliminary fashion the effectiveness of this approach for improving upper extremity function after motor complete high tetraplegia. Thus, future studies are warranted. Possible mechanisms are discussed.